Breakwater Capital Group’s AstraZeneca AZN Stock Holding History

Breakwater Capital Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$543K	Sell	2,866 -31	-1%	-$5.83K	0.07%	237
2026 Q1	$571K	Sell	2,897 -9	-0.3%	-$1.74K	0.08%	226
2025 Q4	$534K	Hold	2,906	–	–	0.07%	220
2025 Q3	$446K	Sell	2,906 -55	-2%	-$8.32K	0.07%	241
2025 Q2	$414K	Buy	2,961 +42	+1%	+$5.89K	0.07%	240
2025 Q1	$429K	Buy	+2,919	New	+$422K	0.08%	221
2024 Q4	–	Sell	-1,588	Closed	-$247K	–	288
2024 Q3	$247K	Buy	1,588 +261	+20%	+$42.1K	0.05%	255
2024 Q2	$207K	Buy	+1,327	New	+$200K	0.05%	270

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Breakwater Capital Group's AZN Position: Q2 2026 in Review

Breakwater Capital Group reduced its AstraZeneca (AZN) stake by 1.1% in Q2 2026, selling an estimated $5.83K and leaving 2,866 shares worth $543K. The position accounts for 0.07% of the portfolio, ranked #237.

Breakwater Capital Group first reported a position in AZN in Q2 2024 and has held it in 8 quarters since. The position peaked at $571K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Breakwater Capital Group held 2,866 shares of AstraZeneca worth $543K as of Q2 2026.
Breakwater Capital Group sold 31 AstraZeneca shares in Q2 2026, an estimated $5.83K.
AstraZeneca made up 0.07% of Breakwater Capital Group's portfolio in Q2 2026, its #237 holding.
Breakwater Capital Group first reported a position in AstraZeneca in Q2 2024 and has held it in 8 quarters since.
Breakwater Capital Group's AstraZeneca position peaked at $571K in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Breakwater Capital Group's 13F filing for Q2 2026, filed 8 Jul 2026.